Innovative Nanotechnology for Drug Delivery Systems

Dear Colleagues,

Nanotechnology has become a tool that is extensively utilized for the successful delivery of therapeutics, from small-molecule drugs to biologics. The recent development of smart biomaterials has contributed significantly to broadening the current repertoire of nanoparticles. However, the pre-clinical validation of such nanotechnology is yet to translate into clinical success for many medical conditions. There remains an unmet, immediate and long-term need for advanced systems with specific functionalities that are able to overcome physicochemical and biological barriers to successful drug delivery; these include tissue specificity, tissue penetration/diffusion, cellular uptake, endosomal escape, controlled release, etc.

This Special Issue of Bioengineering, entitled “Innovative Nanotechnology for Drug Delivery Systems”, will present original research papers and comprehensive reviews that describe truly innovative and orthogonal strategies for the development of nanotechnology and that can overcome any of the aforementioned barriers. The submission of research that involves personalization or machine learning in the development of nanotechnology is strongly encouraged. We look forward to receiving and presenting your exciting and impactful research to the nanotechnology/drug delivery audience.

Dr. Jayoung Kim
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• drug delivery systems
• nanoparticles
• personalization
• precision medicine
• machine learning